Inactivated SARS-CoV-2 vaccine (Vero cell)（Beijing Institute of Biological Products）

新型冠状病毒灭活疫苗（Vero细胞）（北京生物制品研究所）

Report date: 2023/11/01 10:57:52

Base Information

Drug NameInactivated SARS-CoV-2 vaccine (Vero cell)（Beijing Institute of Biological Products）
Drug Alias NameSARS-COV-2 Vaccine (Vero cell), Inactivated（Beijing Institute of Biological Products）BBIBP-CorV众爱可维COVILO
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Biological material > Viral vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)
Approved Indications in ChinaCoronavirus Disease 2019 (COVID-19)
Original Approved Country/TerritoryUnited Arab Emirates
Original Approved Date2020/12/09
Country/TerritoryBahrainUnited Arab EmiratesArgentina +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Institute Of Biological Products Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesLaboratorio Elea Phoenix SaPT Kimia Farma (Persero) TbkWuhan Institute Of Biological Products Co Ltd +[4] 
Inactive CompaniesChina National Biotec Holding Ltd
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeJ07B
Related LinksN/A